KARSEN PERRY A - Insider Non-Derivative Transactions at Jounce Therapeutics, Inc. (JNCE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 3, 2023, KARSEN PERRY A's relationship to Jounce Therapeutics, Inc. (JNCE) is Director, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JNCE insiders.
Data Source: SEC.
KARSEN PERRY A - Insider Non-Derivative Transactions at JNCE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 4, 2023 | U -- (Common Stock) | 5000 | 0 | 0 |